Obese women with ER-positive/HER2-negative breast cancer have poorer survival rates

Obesity was associated with worse overall and disease-free survival in women with operable breast cancer treated with adjuvant chemotherapy, but for the first time, researchers observed this finding in only a specific subset of patients – those with estrogen receptor (ER)-positive/HER2-negative disease.

Read the whole article on Physorg

More from Physorg